Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Penicillin G Potassium
Therapeutic Area : Oncology
Study Phase : Phase III
Sponsor : Proteon Therapeutics
Deal Size : $42.5 million
Deal Type : Merger
ArTara Therapeutics Completes Merger Transaction with Proteon Therapeutics
Details : ArTara therapeutics completes merger with proteon therapeutics. The net proceeds from this financing will fund development of ArTara’s lead assets, TARA-002 and intravenous (IV) choline chloride.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
January 09, 2020
Lead Product(s) : Penicillin G Potassium
Therapeutic Area : Oncology
Highest Development Status : Phase III
Sponsor : Proteon Therapeutics
Deal Size : $42.5 million
Deal Type : Merger
Reset All
